Stibbe advises Agendia

Stibbe advises Agendia

Stibbe advises Agendia

26.07.2018 NL law

Stibbe advised Agendia on securing a $35 million investment from funds managed by Athyrium Capital Management.

Agendia is a privately held, leading precision oncology company that develops and markets genomic diagnostic products. Proceeds from the financing will accelerate Agendia's commercial expansion in the U.S. and international markets and will enable Agendia to establish new collaborative research programs.


Related experience

This website uses cookies. Some of these cookies are essential for the technical functioning of our website and you cannot disable these cookies if you want to read our website. We also use functional cookies to ensure the website functions properly and analytical cookies to personalise content and to analyse our traffic. You can either accept or refuse these functional and analytical cookies.

Privacy – en cookieverklaring